These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18277616)

  • 41. Solid-state study of mepivacaine hydrochloride.
    Giannellini V; Bambagiotti-Alberti M; Bartolucci G; Bruni B; Coran SA; Costantino F; Di Vaira M
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):444-54. PubMed ID: 15950424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of moricizine hydrochloride polymorphs.
    Wu LS; Torosian G; Sigvardson K; Gerard C; Hussain MA
    J Pharm Sci; 1994 Oct; 83(10):1404-6. PubMed ID: 7884659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
    Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM
    J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physicochemical study of percutaneous absorption enhancement by dimethyl sulfoxide: dimethyl sulfoxide mediation of vidarabine (ara-A) permeation of hairless mouse skin.
    Kurihara-Bergstrom T; Flynn GL; Higuchi WI
    J Invest Dermatol; 1987 Sep; 89(3):274-80. PubMed ID: 3624900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transdermal delivery of praziquantel: effects of solvents on permeation across rabbit skin.
    Zheng XS; Duan CZ; Xiao ZD; Yao BA
    Biol Pharm Bull; 2008 May; 31(5):1045-8. PubMed ID: 18451545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solvation of dried dentin matrix by water and other polar solvents.
    Pashley DH; Carvalho RM; Tay FR; Agee KA; Lee KW
    Am J Dent; 2002 Apr; 15(2):97-102. PubMed ID: 12092999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of solvents on skin absorption of nonvolatile lipophilic and polar solutes under finite dose conditions.
    Intarakumhaeng R; Wanasathop A; Li SK
    Int J Pharm; 2018 Jan; 536(1):405-413. PubMed ID: 29180256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solid-state investigation of piroxicam benzoate.
    Cetina-Cizmek B; Tudja M; Mestrović E; Zovko M; Zorc B; Tudja P
    Acta Pharm; 2003 Sep; 53(3):165-73. PubMed ID: 14769240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystallographic characterization of several erythromycin A solvates: the environment of the solvent molecules in the crystal lattice.
    Henry R; Zhang GG
    J Pharm Sci; 2007 May; 96(5):1251-7. PubMed ID: 17455320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of solid-state NMR line widths of ibuprofen in drug formulations.
    Barich DH; Davis JM; Schieber LJ; Zell MT; Munson EJ
    J Pharm Sci; 2006 Jul; 95(7):1586-94. PubMed ID: 16732561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Solid-state characterization of mefenamic acid.
    Panchagnula R; Sundaramurthy P; Pillai O; Agrawal S; Raj YA
    J Pharm Sci; 2004 Apr; 93(4):1019-29. PubMed ID: 14999737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physicochemical characterization of high- and low-melting phenylephrine oxazolidines.
    Qiu Y; Schoenwald RD; Guillory JK
    Pharm Res; 1993 Oct; 10(10):1507-15. PubMed ID: 8272415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physicochemical characterization of 9,10-anthraquinone 2-carboxylic acid.
    Tsai SY; Kuo SC; Lin SY
    J Pharm Sci; 1993 Dec; 82(12):1250-4. PubMed ID: 8308705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan.
    Subedi RK; Ryoo JP; Moon C; Choi HK
    Int J Pharm; 2011 Oct; 419(1-2):209-14. PubMed ID: 21843607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of meloxicam/ethanolamine salt formation on percutaneous absorption of meloxicam.
    Ki HM; Choi HK
    Arch Pharm Res; 2007 Feb; 30(2):215-21. PubMed ID: 17366744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical alterations in duckweed and algae induced by carrier solvents: Selection of an appropriate solvent in toxicity testing.
    Hu LX; Tian F; Martin FL; Ying GG
    Environ Toxicol Chem; 2017 Oct; 36(10):2631-2639. PubMed ID: 28337778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery.
    Bakhbakhi Y; Charpentier PA; Rohani S
    Int J Pharm; 2006 Feb; 309(1-2):71-80. PubMed ID: 16412594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between crystal habit and the composition of solvated and nonsolvated cholesterol crystals.
    Garti N; Karpuj L; Sarig S
    J Lipid Res; 1981 Jul; 22(5):785-91. PubMed ID: 7288285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.